Nonlinear Pricing in Drug Benefits and Medication Use: The Case of Statin Compliance in Medicare Part D
Version of Record online: 19 DEC 2013
© Health Research and Educational Trust
Health Services Research
Volume 49, Issue 3, pages 910–928, June 2014
How to Cite
Jung, K., Feldman, R. and McBean, A. M. (2014), Nonlinear Pricing in Drug Benefits and Medication Use: The Case of Statin Compliance in Medicare Part D. Health Services Research, 49: 910–928. doi: 10.1111/1475-6773.12145
- Issue online: 16 MAY 2014
- Version of Record online: 19 DEC 2013
- Centers for Medicare and Medicaid Services. Grant Number: HHSM-500-2005-00271
|hesr12145-sup-0001-Appendix-SA1.pdf||Word document||664K||Appendix SA1: Author Matrix.|
Table S1: Results from the Selection Equation (Choice of Gap Coverage).
Table S2: Relation between Part A/B Payment Rates and Enrollees' Annual Spending on Part D–Covered Drugs.
Table S3: Relation between Part A/B Payment Rates and the Number of Therapeutic Classes of Drugs Used by Enrollees.
Table S4: Results from Estimation of Pre-Gap Copayments.
Table S5: Marginal Effects for the Probability of Hitting the Gap.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.